04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Recently, the Occupational Safety and Health Commission (OSHRC or Commission) issued a decision in S...
Read More >
Unused vacation time can represent a substantial liability on the books for many employers. Therefor...
Read More >
In 2019, the Department of Labor (DOL) continued its trend of providing limited advance guidance und...
Read More >
New York’s Workers’ Compensation Law, as it stands, permits an injured worker to treat with any ph...
Read More >
The FTI Journal continues its look at opportunities for private equity in distressed M&A given the p...
Read More >
U.S. Citizenship & Immigration Services (USCIS) has informed all employers to continue using the For...
Read More >